Reese Yeh - Profile and Investment Details

Investor Profile

Reese Yeh is a Private Equity Firm, Venture Capital based in with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics, Atea Pharmaceuticals, Imperative Care, Nuvation Bio, Mavrik Dental Systems, Alzheon, UNUM Therapeutics, Pulmonx, Hua Medicine, Tunitas Therapeutics, Duoning Biotech, Cyteir Therapeutics, Conventus Orthopaedics, Sagimet Biosciences, GenFleet Therapeutics, Quantum Surgical, Rapid Micro Biosystems, Mainstay Medical, I-Mab Biopharma, Grail, Synlogic, Jinxin Fertility, IsoPlexis, Venclose, ImmunGene, TESARO, Chinook Therapeutics, Sorrento Therapeutics, RefleXion Medical, Wacai.com, Shockwave Medical, Otonomy, Akeso Biopharma, LinkDoc Technology, CG Oncology. Over time, Reese Yeh has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Reese Yeh is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Women Led, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Genomics, Financial Services, Medical, Therapeutics, mHealth, Media and Entertainment, Personal Health, Emergency Medicine, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Reese Yeh, as their portfolio suggests a familiarity and interest in this area.

Understanding Reese Yeh’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.